Defining super-enhancer landscape in triple-negative breast cancer by multiomic profiling
Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype with poor prognostic outcomes. Here the authors characterize super-enhancer heterogeneity and they identify genes that are specifically regulated by TNBC-specific super-enhancers, including FOXC1, MET and ANLN.
Guardado en:
Autores principales: | Hao Huang, Jianyang Hu, Alishba Maryam, Qinghua Huang, Yuchen Zhang, Saravanan Ramakrishnan, Jingyu Li, Haiying Ma, Victor W. S. Ma, Wah Cheuk, Grace Y. K. So, Wei Wang, William C. S. Cho, Liang Zhang, Kui Ming Chan, Xin Wang, Y. Rebecca Chin |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/abbe2a31ae264afda36fe681ddcc9d63 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Tendon and multiomics: advantages, advances, and opportunities
por: Paula Sarmiento, et al.
Publicado: (2021) -
Multiomics analysis reveals CT83 is the most specific gene for triple negative breast cancer and its hypomethylation is oncogenic in breast cancer
por: Chen Chen, et al.
Publicado: (2021) -
Single-Cell Multiomics Analysis for Drug Discovery
por: Sam F. Nassar, et al.
Publicado: (2021) -
Integrative multiomics-histopathology analysis for breast cancer classification
por: Yasha Ektefaie, et al.
Publicado: (2021) -
Multiomics characteristics of neurogenesis-related gene are dysregulated in tumor immune microenvironment
por: Ben Wang, et al.
Publicado: (2021)